Background and insight
MedicalXpress reports on a study published in the New England Journal of Medicine alongside the American Heart Association’s scientific meeting in November 2026. According to the summary, among older adults without known cardiovascular disease, discontinuing statin treatment was noninferior to continuing it when the medicine was being used for primary prevention. Primary prevention means treatment intended to reduce risk before a known cardiovascular event has occurred.
A finding like this applies to the group studied and the question the study asked; it does not determine what is right for everyone. Statins may be prescribed for different reasons, and a previous heart attack, stroke or other known vascular disease changes the assessment. Age, overall risk, possible side effects, other conditions and personal preferences belong in a discussion with a healthcare professional. Do not stop or change your dose on your own.
What does this mean for your everyday life?
The study may give some older patients and clinicians a reason to review whether preventive treatment still fits the person’s health situation and goals. A medication review is not simply about reducing the number of pills; it is about weighing expected benefits, downsides and what matters to the individual.
💡 How to use this knowledge
- If you take a statin, write down why it was started, your dose, any side effects and whether you have previously had cardiovascular disease. Bring the notes to your next appointment.
- Ask your clinician: “Is this primary or secondary prevention for me? How do my age and other health conditions affect the potential benefit, and what should we monitor if treatment changes?” Do not stop until you have made a plan together.